Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Zelazowska MA"'
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 May 03. Date of Electronic Publication: 2024 May 03.
Autor:
Hogan CH; Graduate Program in Genetics, Stony Brook University, Stony Brook, New York, USA.; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Owens SM; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Reynoso GV; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Liao Y; Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Meyer TJ; CCR Collaborative Bioinformatics Resource, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Liu B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li X; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Grosskopf AK; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Khairallah C; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Kirillov V; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Reich NC; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Sheridan BS; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gewurz BE; Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Hickman HD; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Forrest JC; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Krug LT; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
Publikováno v:
MBio [mBio] 2024 Feb 14; Vol. 15 (2), pp. e0299823. Date of Electronic Publication: 2024 Jan 03.
Autor:
Mu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Chen Z; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Plummer JB; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Dong Q; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA; Molecular and Cellular Biology Program, Stony Brook University, Stony Brook, NY 11794, USA., Krug LT; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. Electronic address: kmcbride@mdanderson.org.
Publikováno v:
DNA repair [DNA Repair (Amst)] 2023 Aug; Vol. 128, pp. 103515. Date of Electronic Publication: 2023 Jun 08.
Autor:
Liu KJ; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Viruses [Viruses] 2023 May 26; Vol. 15 (6). Date of Electronic Publication: 2023 May 26.
Autor:
Mu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Plummer JB; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Paul S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Dong Q; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA.; Molecular and Cellular Biology Program, Stony Brook University, Stony Brook, NY 11794, USA., Chen Z; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA., Krug LT; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794, USA.; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 18. Date of Electronic Publication: 2023 May 18.
Autor:
Hogan CH; Graduate Program in Genetics, Stony Brook University, Stony Brook, New York, USA.; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Owens SM; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Reynoso GV; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Kirillov V; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Meyer TJ; CCR Collaborative Bioinformatics Resource, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li X; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Chikhalya A; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Dong Q; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.; Graduate Program of Molecular and Cellular Biology, Stony Brook University, Stony Brook, New York, USA., Khairallah C; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Reich NC; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Sheridan B; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hearing P; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA., Hickman HD; Viral Immunity and Pathogenesis Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Forrest JC; Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Krug LT; HIV & AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, MD, USA.; Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Mar 22. Date of Electronic Publication: 2023 Mar 22.
Autor:
Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957 USA., McBride K; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957 USA., Krug LT; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Viruses [Viruses] 2020 Jul 23; Vol. 12 (8). Date of Electronic Publication: 2020 Jul 23.
Autor:
Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA., Dong Q; Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY, USA.; Graduate Program of Molecular and Cellular Biology, Stony Brook University, Stony Brook, NY, USA., Plummer JB; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA., Zhong Y; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA., Liu B; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA., Krug LT; Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA kmcbride@mdanderson.org.
Publikováno v:
Life science alliance [Life Sci Alliance] 2020 Feb 06; Vol. 3 (3). Date of Electronic Publication: 2020 Feb 06 (Print Publication: 2020).
Autor:
Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bhelmink@mdanderson.org., Reddy SM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao J; Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Basar R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thakur R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yizhak K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Sade-Feldman M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Broad Institute of the Massachusetts Institute of Technology, Boston, MA, USA., Blando J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xi Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao H; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu W; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LeBleu VS; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kugeratski FG; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arora R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaudreau PO; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reuben A; Department of Thoracic / Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zapassodi R; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hudgens CW; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ledesma DA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ong S; Nanostring Technologies, Seattle, WA, USA., Bailey M; Nanostring Technologies, Seattle, WA, USA., Warren S; Nanostring Technologies, Seattle, WA, USA., Rao D; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Krijgsman O; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rozeman EA; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Peeper D; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blank CU; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schumacher TN; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Butterfield LH; Departments of Medicine, Surgery, Immunology and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, USA., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kalluri R; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Allison J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petitprez F; INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France.; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France., Fridman WH; INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France., Sautès-Fridman C; INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.; University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France., Hacohen N; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Broad Institute of the Massachusetts Institute of Technology, Boston, MA, USA., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
Publikováno v:
Nature [Nature] 2020 Jan; Vol. 577 (7791), pp. 549-555. Date of Electronic Publication: 2020 Jan 15.
Autor:
Mu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX., Zelazowska MA; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX., McBride KM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX kmcbride@mdanderson.org.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2017 Dec 04; Vol. 214 (12), pp. 3543-3552. Date of Electronic Publication: 2017 Nov 09.